Lindorfer MA - Search Results

1

Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.

Lindorfer MA, Hahn CS, Foley PL, Taylor RP. Lindorfer MA, et al. Immunol Rev. 2001 Oct;183:10-24. doi: 10.1034/j.1600-065x.2001.1830102.x. Immunol Rev. 2001. PMID: 11782244 Review.

2

2H nuclear magnetic resonance of the gramicidin A backbone in a phospholipid bilayer.

Prosser RS, Davis JH, Dahlquist FW, Lindorfer MA. Prosser RS, et al. Among authors: lindorfer ma. Biochemistry. 1991 May 14;30(19):4687-96. doi: 10.1021/bi00233a008. Biochemistry. 1991. PMID: 1709361

3

Kinetic and equilibrium studies of concanavalin A activation by calcium ions.

Sherry AD, Lindorfer MA, Adams-Stemler P, Milanes OA. Sherry AD, et al. Among authors: lindorfer ma. Biochemistry. 1981 Jun 9;20(12):3492-9. doi: 10.1021/bi00515a029. Biochemistry. 1981. PMID: 7260052 No abstract available.

4

How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?

Nardin A, Lindorfer MA, Taylor RP. Nardin A, et al. Among authors: lindorfer ma. Mol Immunol. 1999 Sep-Oct;36(13-14):827-35. doi: 10.1016/s0161-5890(99)00103-0. Mol Immunol. 1999. PMID: 10698336 Review.

5

Targeting of cancer cells with monoclonal antibodies specific for C3b(i).

Sokoloff MH, Nardin A, Solga MD, Lindorfer MA, Sutherland WM, Bankovich AJ, Zhau HE, Chung LW, Taylor RP. Sokoloff MH, et al. Among authors: lindorfer ma. Cancer Immunol Immunother. 2000 Dec;49(10):551-62. doi: 10.1007/s002620000140. Cancer Immunol Immunother. 2000. PMID: 11129326

6

A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.

Lindorfer MA, Schuman TA, Craig ML, Martin EN, Taylor RP. Lindorfer MA, et al. J Immunol Methods. 2001 Feb 1;248(1-2):125-38. doi: 10.1016/s0022-1759(00)00348-3. J Immunol Methods. 2001. PMID: 11223074

7

Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies.

Lindorfer MA, Nardin A, Foley PL, Solga MD, Bankovich AJ, Martin EN, Henderson AL, Price CW, Gyimesi E, Wozencraft CP, Goldberg JB, Sutherland WM, Taylor RP. Lindorfer MA, et al. J Immunol. 2001 Aug 15;167(4):2240-9. doi: 10.4049/jimmunol.167.4.2240. J Immunol. 2001. PMID: 11490011

8

Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.

Henderson AL, Lindorfer MA, Kennedy AD, Foley PL, Taylor RP. Henderson AL, et al. Among authors: lindorfer ma. J Immunol Methods. 2002 Dec 15;270(2):183-97. doi: 10.1016/s0022-1759(02)00296-x. J Immunol Methods. 2002. PMID: 12379324

9

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.

Kennedy AD, Solga MD, Schuman TA, Chi AW, Lindorfer MA, Sutherland WM, Foley PL, Taylor RP. Kennedy AD, et al. Among authors: lindorfer ma. Blood. 2003 Feb 1;101(3):1071-9. doi: 10.1182/blood-2002-03-0876. Epub 2002 Sep 5. Blood. 2003. PMID: 12393727 Free article.

10

B cell complement receptor 2 transfer reaction.

Lindorfer MA, Jinivizian HB, Foley PL, Kennedy AD, Solga MD, Taylor RP. Lindorfer MA, et al. J Immunol. 2003 Apr 1;170(7):3671-8. doi: 10.4049/jimmunol.170.7.3671. J Immunol. 2003. PMID: 12646632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page